These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9593866)

  • 1. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis.
    Jackson JR; Bolognese B; Mangar CA; Hubbard WC; Marshall LA; Winkler JD
    Biochim Biophys Acta; 1998 May; 1392(1):145-52. PubMed ID: 9593866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
    Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
    J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
    Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
    Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
    Winkler JD; Sung CM; Hubbard WC; Chilton FH
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of leukotriene and platelet-activating factor synthesis in rat alveolar macrophages.
    Shamsuddin M; Anderson J; Smith LJ
    Am J Respir Cell Mol Biol; 1995 Jun; 12(6):697-704. PubMed ID: 7766433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.
    Christie PE; Henderson WR
    Clin Allergy Immunol; 2002; 16():233-54. PubMed ID: 11577541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation].
    Ou-Yang XY; Wang WJ; Liao WH; Chen XH
    Yao Xue Xue Bao; 2005 Apr; 40(4):311-5. PubMed ID: 16011257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
    Bozza PT; Payne JL; Goulet JL; Weller PF
    J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP; McColl SR; Braquet P; Borgeat P
    Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipid mediators in asthma (current views and perspectives).
    König W; Schönfeld W; Knöller J; Köller M
    Allergol Immunopathol (Madr); 1988; 16(5):289-98. PubMed ID: 3147587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism.
    Fradin A; Zirrolli JA; Maclouf J; Vausbinder L; Henson PM; Murphy RC
    J Immunol; 1989 Dec; 143(11):3680-5. PubMed ID: 2555415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
    Qian C; Hwang SB; Libertine-Garahan L; Eckman JB; Cai X; Scannell RT; Yeh CG
    Pharmacol Res; 2001 Sep; 44(3):213-20. PubMed ID: 11529688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.
    Tool AT; Verhoeven AJ
    Arzneimittelforschung; 1995 Oct; 45(10):1110-4. PubMed ID: 8595070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity.
    Tramposch KM; Steiner SA; Stanley PL; Nettleton DO; Franson RC; Lewin AH; Carroll FI
    Biochem Biophys Res Commun; 1992 Nov; 189(1):272-9. PubMed ID: 1449483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation.
    Seo KH; Lee HS; Jung B; Ko HM; Choi JH; Park SJ; Choi IH; Lee HK; Im SY
    Cancer Res; 2004 Sep; 64(18):6482-8. PubMed ID: 15374958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism.
    Christman BW; Christman JW; Dworski R; Blair IA; Prakash C
    J Immunol; 1993 Aug; 151(4):2096-104. PubMed ID: 8393898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.